Drawing for KLEVEPTO

USPTO serial 86501753

KLEVEPTO

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
HENRY, NAKIA D
Law office
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KLEVEPTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Angela L. Wilson

ANGELA L. WILSON GLAXOSMITHKLINEFive Moore DriveLegal Global Trademarks, Mailstop: 5.5AResearch Triangle Park, NC 27709-0183

Goods and services

ClassDescriptionStatusFirst use
005(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines (Based on 44(e))Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; VaccinesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2015FIXDELECTRONIC RECORD REVIEW COMPLETE—
Sep 15, 2015MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Sep 15, 2015ABN5ABANDONMENT - AFTER PUBLICATION—
Sep 10, 2015EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Aug 28, 2015ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jul 14, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 14, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 23, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 8, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 8, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 14, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 14, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 11, 2015ALIEASSIGNED TO LIE—
May 5, 2015ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 17, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 17, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Apr 17, 2015CNSLSUSPENSION LETTER WRITTEN—
Apr 17, 2015DOCKASSIGNED TO EXAMINER—
Jan 23, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 16, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance